Impact Therapeutics Limited

Impact Therapeutics Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U51909MH2010PLC211564 Incorporated 29 December 2010 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2024
₹1,499.49 Cr
▲ 75.00% YoY
EBITDA · FY 2024
Locked
In full report
Net profit · FY 2024
Locked
In full report
Authorised capital
₹15.1 Cr
Registered with MCA
Paid-up capital
₹15.1 Cr
Issued & subscribed
Open charges
₹128 Cr
Satisfied ₹15 Cr
Company age
16 yrs
Est. 2010
Last financials
Mar 2024
Balance sheet date

About Impact Therapeutics Limited

Data last updated: 05 January 2026

Impact Therapeutics Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 29 December 2010, the company has been in operation for over 16 years.

Registered with ROC Mumbai under CIN U51909MH2010PLC211564.

Capital: an authorised share capital of ₹15.1 Cr and a paid-up capital of ₹15.1 Cr. Formerly known as Miles Tradexim Private Limited and Impact Therapeutics Limited. It is led by directors including Ambarish Chatterjee and Pooja Rajan Ambure.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: 1004 10Th Floor Lodha Supremus Powai Saki Vihar Road Opp Mtnl Office Powai, Mumbai, Maharashtra, India – 400072.

As per the financials filed for FY 2024, the company reported a revenue of ₹1,499.49 Cr, a growth of 75% compared to the previous year.

Its group structure includes 1 subsidiary.

As per MCA filings, the company has open charges of ₹128 Cr and satisfied charges of ₹15 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medecdragon.com.

Company Details of Impact Therapeutics Limited
CIN U51909MH2010PLC211564
Registration Number 211564
Incorporation Date 29 December 2010
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    1004 10Th Floor Lodha Supremus Powai Saki Vihar Road Opp Mtnl Office Powai, Mumbai, Maharashtra, India – 400072
  • Industry
    Pharma, API Manufacturers
Company report
Impact Therapeutics Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Impact Therapeutics Limited report

Financials, compliance, directors, charges, ownership and filings for Impact Therapeutics Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Impact Therapeutics Limited

Impact Therapeutics Limited has undergone 2 name changes throughout its history. The company was previously known as Miles Tradexim Private Limited, and Impact Therapeutics Limited. The current legal name is Impact Therapeutics Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Impact Therapeutics Limited Current
Miles Tradexim Private Limited Previous

CIN History of Impact Therapeutics Limited

Impact Therapeutics Limited has one previous CIN (Corporate Identification Number): U51909MH2010PTC211564. The current CIN is U51909MH2010PLC211564, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U51909MH2010PLC211564 Current
U51909MH2010PTC211564 Previous

Business Activity of Impact Therapeutics Limited

Impact Therapeutics Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading Locked
Premium access

Business activity turnover details for Impact Therapeutics Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Impact Therapeutics Limited

Impact Therapeutics Limited is audited by CHATURVEDI & PATEL for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
CHATURVEDI & PATEL Locked Locked Locked
Premium access

Complete auditor history for Impact Therapeutics Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Impact Therapeutics Limited

Impact Therapeutics Limited is currently managed by 3 directors, with 18 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Ambarish Chatterjee Director 25 Jan 2024 2 Years 6 Months Current
Pooja Rajan Ambure Director 25 Jan 2024 2 Years 6 Months Current
Rakesh Grihpati Singh Additional Director 15 Jul 2025 1 Years 0 Months Current

Financials of Impact Therapeutics Limited FY 2024 filings available

Impact Therapeutics Limited reported revenue of ₹1,499.49 Cr (up 75.00% YoY) for FY 2024.

Revenue · FY 2024
₹1,499.49 Cr ▲ 75.00%
Premium access

Ten-year financial statements for Impact Therapeutics Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Impact Therapeutics Limited

Premium access

Shareholding and ownership data for Impact Therapeutics Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Group Structure of Impact Therapeutics Limited

Impact Therapeutics Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Impact Therapeutics Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Medec Infra Private Limited U28990MH2021PTC360696 Locked

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Impact Therapeutics Limited

Open charges
₹128 Cr
Satisfied charges
₹15 Cr
Breakdown by lending institutions
Axis Bank Limited₹128.00 Cr
Latest charge details
DateLenderAmountStatus
01 Jun 2023 Axis Bank Limited ₹20 Cr Open
14 Feb 2023 Axis Bank Limited ₹20 Cr Open
16 Feb 2022 Axis Bank Limited ₹88 Cr Open
11 Apr 2025 Hdfc Bank Limited ₹15 Cr Satisfied

Total charge records: 4 View all charges

Employees and EPFO Compliance at Impact Therapeutics Limited

View historical data on people associated with Impact Therapeutics Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Impact Therapeutics Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Impact Therapeutics Limited

Premium access

GST registrations and filing compliance for Impact Therapeutics Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Impact Therapeutics Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Impact Therapeutics Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Impact Therapeutics Limited

Premium access

MSME payment history for Impact Therapeutics Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Impact Therapeutics Limited

Premium access

Corporate group structure for Impact Therapeutics Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Impact Therapeutics Limited

Premium access

MCA filings and documents for Impact Therapeutics Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Impact Therapeutics Limited

Charges
15 Nov 2025
A charge registered on 11 Apr 2025 via Charge ID 101103145 with Hdfc Bank Limited was fully satisfied on 15 Nov 2025.
Directors
15 Jul 2025
Rakesh Grihpati Singh was appointed as a Additional Director on 15 Jul 2025 & has been associated with this company since 1 year 30 days.
Charges
11 Apr 2025
A charge with Hdfc Bank Limited amounted to Rs. 15.00 Cr with Charge ID 101103145 was registered on 11 Apr 2025.
Activity
30 Sep 2024
Impact Therapeutics Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Activity
31 Mar 2024
Impact Therapeutics Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Directors
25 Jan 2024
Ambarish Chatterjee was appointed as a Director on 25 Jan 2024 & has been associated with this company since 2 years 6 months.

Frequently Asked Questions about Impact Therapeutics Limited

Impact Therapeutics Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 29 December 2010 (16+ years old) and is registered under CIN U51909MH2010PLC211564.

Impact Therapeutics Limited reported revenue of ₹1,499.49 Cr for FY 2024 (up 75.00% YoY).

The current directors of Impact Therapeutics Limited are:

The primary industry of Impact Therapeutics Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Impact Therapeutics Limited can be reached at the registered office: 1004 10Th Floor Lodha Supremus Powai Saki Vihar Road Opp Mtnl Office Powai, Mumbai, Maharashtra, India – 400072, or through the website medecdragon.com.

The authorised capital is ₹15.1 Cr, and the paid-up capital is ₹15.1 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available